Hepatology Digest: Due to the lack of good biomarkers does alpha-fetoprotein have any utility in terms of detecting those who have higher risk of liver cancer?
2
更进一步，使用生物因子的临床实验证实能延长肝癌患者的生存时间。
Further clinical trials using biologic agents are warranted to prolong the survival in HCC patients.
3
目的评价肝动脉化疗栓塞联合生物治疗对原发性肝癌的疗效。
Objective Evaluating the effect of hepatic artery embolism chemotherapy combined with biological therapy to treat primary liver cancer.
点击反馈